Kiley Juergens Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.87M Sell
5,724
-127
-2% -$130K 1.08% 17
2026
Q1
$5.38M Buy
+5,851
New +$5.93M 0.95% 19
2018
Q4
Sell
-1,689
Closed -$181K 381
2018
Q3
$181K Buy
1,689
+37
+2% +$3.7K 0.14% 107
2018
Q2
$140K Buy
+1,652
New +$136K 0.13% 109
2018
Q1
Sell
-528
Closed -$44K 378
2017
Q4
$44K Buy
+528
New +$44.9K 0.04% 215

Other funds holding LLY

Kiley Juergens Wealth Management's LLY Position: Q2 2026 in Review

Kiley Juergens Wealth Management reduced its Eli Lilly (LLY) stake by 2.2% in Q2 2026, selling an estimated $130K and leaving 5,724 shares worth $6.87M. The position accounts for 1.08% of the portfolio, ranked #17.

Kiley Juergens Wealth Management first reported a position in LLY in Q4 2017 and has held it in 5 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kiley Juergens Wealth Management held 5,724 shares of Eli Lilly worth $6.87M as of Q2 2026.
  • Kiley Juergens Wealth Management sold 127 Eli Lilly shares in Q2 2026, an estimated $130K.
  • Eli Lilly made up 1.08% of Kiley Juergens Wealth Management's portfolio in Q2 2026, its #17 holding.
  • Kiley Juergens Wealth Management first reported a position in Eli Lilly in Q4 2017 and has held it in 5 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kiley Juergens Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.